Pill Identifier App

Parvo Shield

This page contains information on Parvo Shield for veterinary use.
The information provided typically includes the following:
  • Parvo Shield Indications
  • Warnings and cautions for Parvo Shield
  • Direction and dosage information for Parvo Shield

Parvo Shield

This treatment applies to the following species:
Manufacturer: Novartis (Farm Animal)

Parvovirus Vaccine

Killed Virus

For Use In Animals Only

Parvo Shield Indications

For use in healthy swine as an aid in the prevention of disease caused by porcine parvovirus.

ADJUVANT: Aluminum hydroxide.

Directions For Use

Shake well before using. Administer 2 mL intramuscularly or subcutaneously 3-4 weeks prior to breeding. Revaccinate prior to each subsequent breeding. Vaccinate boars annually.

Precautions

Store out of direct sunlight at 2°-7° C (35°-45° F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2010 Novartis; Registered trademark of Novartis AG

50 Doses

100 mL

130-02

NAC No.: 11140265

NOVARTIS ANIMAL HEALTH US, INC.
Farm Animal Business

1447 140TH ST., LARCHWOOD, IA, 51241
Order Desk:   800-843-3386
Technical Information:   800-843-3386
Fax:   336-387-1030
Website:   www.livestock.novartis.com
Email:   technical.services@novartis.com
Every effort has been made to ensure the accuracy of the Parvo Shield information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web4)